Piracetam, a synthetic derivative of the neurotransmitter gamma-aminobutyric acid, belongs to the racetam group of nootropics. Although its applications in the clinical setting are yet to be established, its neuroprotective and anticonvulsant actions have been documented in cognitive disorders and dementia, dyslexia, vertigo, sickle cell anemia, and cortical myoclonus. Its properties are presumed to be related to its ability to modulate neurotransmission which leads to the restoration of cell membrane fluidity.
Noopept is a nootropic compound that is structurally similar to the racetam family of drugs. It is believed to stimulate the production and release of acetylcholine, a neurotransmitter that is involved in learning and memory.
Noopept has been the subject of several studies that have investigated its effects on cognitive function, memory, and neuroprotection. Some of the findings from these studies suggest that Noopept may improve cognitive function and memory, protect against cognitive decline and neurodegeneration, increase levels of brain-derived neurotrophic factor (BDNF), a protein that promotes the growth and survival of neurons, enhance the activity of NMDA receptors, and have anti-inflammatory effects that may be beneficial for neurological conditions.
Noopept is a nootropic compound that is structurally similar to the racetam family of drugs. It is believed to stimulate the production and release of acetylcholine, a neurotransmitter that is involved in learning and memory.
Noopept has been the subject of several studies that have investigated its effects on cognitive function, memory, and neuroprotection. Some of the findings from these studies suggest that Noopept may improve cognitive function and memory, protect against cognitive decline and neurodegeneration, increase levels of brain-derived neurotrophic factor (BDNF), a protein that promotes the growth and survival of neurons, enhance the activity of NMDA receptors, and have anti-inflammatory effects that may be beneficial for neurological conditions.
Coluracetam is a fat-soluble nootropic with purported cognitive-enhancement properties. It has been demonstrated to boost choline uptake in the brain and modulate glutamate receptors, specifically the AMPA receptors.
Oxiracetam is a nootropic compound that belongs to the racetam family. Its mechanism of action is not fully understood, but it is believed to enhance the cholinergic system by increasing the production and release of acetylcholine, a neurotransmitter involved in several functions, including muscle contraction, learning, memory, attention, and arousal.
Oxiracetam is a nootropic compound that belongs tOxiracetam has been shown to improve memory and cognitive function in various research involving individuals with cognitive impairment such as in Alzheimer’s disease, dementia, and brain injuries.
Fasoracetam is a research chemical classified under the racetam family. It has cognitive-enhancing properties and functions by increasing the production of acetylcholine from the cerebral cortex.
Pramiracetam is identified as a central nervous system nootropic agent. It is a synthetic substance that provides cognitive-enhancement effects and supports long-term memory formation.
Sunifiram is an investigational drug that has anti-amnesic properties with stronger and similar effects of piracetam. It functions by binding to AMPA-type glutamate receptors.
support@swisschems.is
+1 (231) 447-1490
